Aeglea BioTherapeutics, Inc. (AGLE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

7.59+0.14 (+1.88%)

As of 12:42PM EST. Market open.

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	7.45
Open	7.45
Bid	7.49 x 1400
Ask	7.63 x 900
Day's Range	7.45 - 7.78
52 Week Range	3.50 - 11.38
Volume	54,335
Avg. Volume	230,081

Market Cap	363.843M
Beta (5Y Monthly)	1.68
PE Ratio (TTM)	N/A
EPS (TTM)	-1.76
Earnings Date	Nov 05, 2020
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	15.63

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

Research Reports

PR Newswire
Aeglea BioTherapeutics Appoints Sara Brownstein to Board of Directors
Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, today announced the appointment of Sara Brownstein to its board of directors. Ms. Brownstein serves as a principal at Baker Bros. Advisors LP.
- BioXcel Therapeutics Appoints June Bray to Board of Directors
  GlobeNewswire
- ROME Therapeutics Appoints Scientist and Entrepreneur Scott Biller, Ph.D. to Board of Directors
  Business Wire
Simply Wall St.
We Think Aeglea BioTherapeutics (NASDAQ:AGLE) Needs To Drive Business Growth Carefully
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Insider Monkey
10 Best Small-Cap Biotech Stocks Under $10 in 2021
In this article we will list the 10 best small-cap biotech stocks under $10 in 2021. Click to skip ahead and see the 5 Best Small-Cap Biotech Stocks Under $10 in 2021. We like healthcare and technology industries because of their above-average long-term growth prospects. Biotechnology is at the intersection of healthcare and technology. According […]